Once Valued At Billions, 23andMe's CEO Considers Privatization To Secure Company's Future - 23andMe Holding (NASDAQ:ME)

Anne Wojcicki, CEO of 23andMe mulls taking the genetics company private amid market challenges. With declining revenue and a focus shift to drug development, the move seeks funding for potential breakthroughs.

Related Keywords

China ,Chinese ,Sergey Brin ,Anne Wojcicki ,Softbank ,Google ,Me Holding Co ,Under Siege ,Wall Street Journal ,Ashkenazi Jewish ,Softbank Backed Genetic Testing Invitae ,